UNBELIEVABLE: 3 | History Defined

Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2022

Upgrades

Benzinga · Oct 19, 2022

3 Residential REITs With The Highest Upside, According To Analysts

Analysts’ opinions are quite important when it comes to stock prices. An upgrade or downgrade can quickly move a stock’s price and lift or lower an analyst’s target price. The target price can also guide investors as to the potential long-term appreciation or depreciation of a stock.

Benzinga · Oct 10, 2022

Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2022

Upgrades

Benzinga · Sep 27, 2022

Benzinga's Top Ratings Upgrades, Downgrades For July 5, 2022

Upgrades

Benzinga · Jul 5, 2022

Evercore ISI Group Maintains In-Line Rating for SkyWest: Here's What You Need To Know

Evercore ISI Group has decided to maintain its In-Line rating of SkyWest (NASDAQ:SKYW) and lower its price target from $35.00 to $25.00. Shares of SkyWest are trading down 1.16% over the last 24 hours, at $22.16 per share. A move to $25.00 would account for a 12.82% increase from the…

Benzinga · Jun 27, 2022

Tesla To $1,150? Here's The Biggest Price Target Changes For Monday

Evercore ISI Group cut United Airlines Holdings, Inc. (NASDAQ: UAL) price target from $56 to $45. United Airlines shares fell 0.8% to trade at $38.22 on Monday.

Benzinga · Jun 27, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2022

Upgrades

Benzinga · Jun 24, 2022

Evercore ISI Group Downgrades CRISPR Therapeutics: Here's What You Need To Know

Evercore ISI Group downgraded its rating of CRISPR Therapeutics (NASDAQ:CRSP) to In-Line with a price target of $60.00, changing its price target from $66.00 to $60.00. Shares of CRISPR Therapeutics are trading up 3.81% over the last 24 hours, at $62.23 per share.

Benzinga · Jun 23, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 23, 2022

Upgrades

Benzinga · Jun 23, 2022

Why DocuSign Shares Are Getting Hammered Today

DocuSign (NASDAQ: DOCU) shares are trading lower by 24.54% to $65.92. The company late Thursday reported worse-than-expected first-quarter EPS results and issued in-line guidance. Evercore ISI Group downgraded the stock from Outperform to In-Line and lowered its price target from $100 to $75.

Benzinga · Jun 10, 2022